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KEY POINTS SUMMARY 
 
 The ventilatory response to reduced oxygen (hypoxia) is biphasic, comprising an initial 
increase in ventilation followed by a secondary depression. 
 Our findings indicate that during hypoxia, astrocytes in the pre-Bötzinger Complex 
(preBötC), a critical site of inspiratory rhythm generation, release a gliotransmitter that acts 
via P2Y1 receptors to stimulate ventilation and reduce the secondary depression. 
 In vitro analyses reveal that ATP excitation of the preBötC involves P2Y1 receptor-mediated 
release of Ca
2+
 from intracellular stores. 
 By identifying a role for gliotransmission and the sites, P2 receptor subtype, and signaling 
mechanisms via which ATP modulates breathing during hypoxia, these data advance 
understanding of mechanisms underlying the hypoxic ventilatory response and highlight the 
significance of purinergic signaling and gliotransmission in homeostatic control. 
 Clinically, these findings are relevant to conditions in which hypoxia and respiratory 
depression are implicated including apnea of prematurity, sleep disordered breathing, and 
congestive heart failure. 
 
ABSTRACT 
 
The hypoxic ventilatory response (HVR) is biphasic, consisting of a phase I increase in 
ventilation followed by a secondary depression (to a steady-state phase II) that can be life-threatening 
in premature infants who suffer from frequent apneas and respiratory depression. ATP released in the 
ventrolateral medulla oblongata during hypoxia attenuates the secondary depression. We explored a 
working hypothesis that vesicular release of ATP by astrocytes in the preBötzinger Complex 
(preBötC) inspiratory rhythm generating network acts via P2Y1 receptors to mediate this effect. 
Blockade of vesicular exocytosis in preBötC astrocytes bilaterally (using an adenoviral vector to 
specifically express tetanus toxin light chain in astrocytes) reduced the HVR in anesthetized rats, 
indicating that exocytotic release of a gliotransmitter within the preBötC contributes to the hypoxia-
induced increases in ventilation. Unilateral blockade of P2Y1 receptors in the preBötC via local 
antagonist injection enhanced the secondary respiratory depression, suggesting that a significant 
component of the phase II increase in ventilation is mediated by ATP acting at P2Y1 receptors. In 
vitro responses of the preBötC inspiratory network, preBötC inspiratory neurons and cultured 
preBötC glia to purinergic agents demonstrated that the P2Y1 receptor-mediated increase in fictive 
inspiratory frequency involves Ca
2+
 recruitment from intracellular stores leading to increases in 
intracellular Ca
2+
 ([Ca
2+
]i) in inspiratory neurons and glia. These data suggest that ATP is released by 
preBötC astrocytes during hypoxia and acts via P2Y1 receptors on inspiratory neurons (and/or glia) to 
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evoke Ca
2+
 release from intracellular stores and an increase in ventilation that counteracts the hypoxic 
respiratory depression. 
 
Abbreviations. AP5, D-(-)-2-amino-5-phosphonopentanoic acid; AVV, adenoviral vector; BME, 
basal medum Eagle; CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; CPA, cyclopiazonic acid; DLH, 
DL-homocysteic acid; eGFP, enhanced green fluorescent protein; GFAP, glial fibrillary acidic 
protein; GPCR, g-protein coupled receptor; HVR, hypoxic ventilatory response; IP3, inositol 
triphosphate; NTS, nucleus tractus solitarius; PKC, protein kinase C; PLC, phospholipase C; PNA, 
phrenic nerve amplitude; preBötC, preBötzinger Complex; SERCA, sarco/endoplasmic reticulum 
Ca
2+
-ATPase; SP, substance P; TeLC, tetanus light chain; TMPAP, transmembrane prostatic acid 
phosphatase; VE, minute ventilation; VLM, ventrolateral medulla; VT, tidal volume. 
 
INTRODUCTION  
 
Acute exposure of mammals to moderate hypoxia evokes a biphasic hypoxic ventilatory 
response (HVR), comprising an initial increase in ventilation within the first minute followed by a 
secondary depression to a lower steady-state (Moss, 2000). The initial, phase I increase is primarily 
attributed to activation of the carotid body chemoreceptors. The secondary depression to a lower 
steady-state, phase II level is largely central in origin (Teppema & Dahan, 2010), is implicated in 
cardiovascular diseases that accompany obstructive sleep apnea (Horner, 2012), and may also be a 
factor in sudden explained death in epilepsy (So, 2008). Interestingly, the HVR changes 
developmentally. In adults, ventilation during phase II remains above baseline. Newborn mammals 
experience a similar phase I increase in ventilation but this is followed by a much larger respiratory 
depression during which ventilation falls below baseline (Moss, 2000). As a result, infants who suffer 
from apnea of prematurity experience frequent apneas that can lead to a life-threatening positive 
feedback loop in which apnea causes hypoxia leading to respiratory depression and greater hypoxia. 
Despite its clinical significance, underlying mechanisms are poorly understood, reflecting, in part, 
variability in the severity of hypoxic stimulus used to study the HVR, as well as developmental and 
species differences in the magnitude of the depression and its underlying mechanisms (Funk, 2013).  
A role for ATP-mediated purinergic signaling in shaping the HVR is supported by data 
showing the release of ATP at the ventrolateral medullary surface and an enhanced secondary 
respiratory depression following application of P2 receptor antagonists in vivo (Gourine et al., 2005; 
Gourine & Funk, 2017). In the in vitro rhythmic slice preparation, the activation of P2 (specifically 
P2Y1) receptors in the preBötzinger Complex (preBötC, a key site of inspiratory rhythm generation) 
produces a robust 2-4 fold increase in the frequency of fictive inspiratory burst activity (Lorier et al., 
2007). Additionally, unanesthetized rats transfected to express transmembrane prostatic acid 
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phosphatase (TMPAP, a potent ectonucleotidase) in the ventrolateral medulla (VLM) to reduce 
endogenous levels of extracellular ATP, or tetanus toxin light chain (TeLC) protein to block vesicular 
release specifically in astrocytes, exhibit a decreased HVR (Angelova et al., 2015). Astrocytes are the 
likely source of ATP, because they have a mitochondria-based hypoxia sensing mechanism that can 
evoke vesicular release of ATP (Angelova et al., 2015). Exocytotic release of ATP from astrocytes 
may contribute directly to the homeostatic hypoxic ventilatory response (Angelova et al., 2015). The 
sites and mechanisms via which ATP causes ventilation to increase during hypoxia remain to be 
determined. Our working model, depicted in Fig. 1, proposes that preBötC astrocytes sense reductions 
in O2 and respond by releasing calcium from intracellular stores (i), which evokes exocytotic release 
of gliotransmitters, including ATP (ii). ATP then activates P2Y1 receptors located on preBötC 
inspiratory neurons (iii), which leads to phospholipase C mediated release of calcium from 
intracellular stores (iv), and the modulation of downstream ion channels via DAG/IP3 or the 
activation of protein kinase C (PKC) (v).  
Within this framework, we first examined the role of gliotransmission in the phase I and II 
components of the HVR using a viral approach to disrupt vesicular release specifically within 
astrocytes of VLM in anesthetized, vagotomized adult rats. Second, based on data from rhythmically-
active brainstem slices demonstrating that ATP excitation of the preBötC is mediated via P2Y1 
receptors  (Funk et al., 1997; Lorier et al., 2004; Lorier et al., 2007; Lorier et al., 2008; Huxtable et 
al., 2009; Zwicker et al., 2011), we tested in anesthetized rats in vivo whether ATP released during 
hypoxia acts in the preBötC via P2Y1 receptors to increase ventilatory output and attenuate the 
secondary depression. Finally, P2Y1 receptors on neurons and astrocytes in other brain regions signal 
primarily through the Gαq/11 G-protein coupled receptor (GPCR) pathway to activate PLC and IP3-
mediated Ca
2+
 release from intracellular stores (Simon et al., 1995; von Kugelgen & Wetter, 2000; 
Sak & Illes, 2005), which modulates neuronal excitability or transmitter release through [Ca
2+
]i-
dependent signaling. To assess the role of the Gαq/11 signaling pathway in mediating the excitatory 
actions of P2Y1 receptors on the preBötC network, we used rhythmic medullary slices from neonatal 
rats to compare the effects of P2Y1 receptor activation on: i) the network response before and after 
chelating intracellular calcium and inhibition of sarco/endoplasmic reticulum Ca
2+
 ATPase (SERCA), 
and ii) the calcium response evoked in inspiratory neurons and preBötC glia by P2Y1 receptor 
activation before and after SERCA inhibition. These data advance our understanding of the sites, 
receptor mechanisms and signaling cascades that underlie the contribution of astroglial purinergic 
signaling to the HVR. 
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METHODS  
 
All the experiments were performed in accordance with the guidelines of the Canadian 
Council on Animal Care and European Commission Directive 2010/63/EU (European Convention for 
the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes) with 
project approval from the respective Institutional Animal Care and Use Ethics Committees. 
 
In vivo methods 
 
Adult in vivo preparations 
Adult male Sprague-Dawley rats (250-350 g) were anesthetized using isofluorane (3% in 
100% O2) and the femoral vein was cannulated. Isofluorane anesthesia was then replaced with 
urethane (1.5-1.7 g/kg) delivered intravenously (i.v.). Additional doses of urethane were given as 
necessary. The femoral artery was cannulated to monitor arterial blood pressure (BP) and blood gases 
in some experiments (as described below). The trachea was cannulated, and the vagus nerves resected 
bilaterally at the mid-cervical level to eliminate confounding effects of vagal reflex stimulation. 
Vagotomy produced a well-described reduction in respiratory frequency. Baseline respiratory 
frequency was within a range of 40 - 55 breaths/min in anesthetized, mechanically ventilated, 
spontaneously breathing rats. From this point there were two variations of the preparation. 
For hypoxia experiments, rats were paralyzed with gallamine triethoiodide or pancuronium 
bromide (10 mg/kg i.v.; 1 mg/kg) and mechanically ventilated with a mix of 20% or 30% O2, balance 
N2 (1 L/min, 60 strokes/min at ~2 ml/stroke, for a tidal volume of 8 ml/Kg). Paralysis and mechanical 
ventilation were used to open chemoreflex loops so that changes in central respiratory drive would not 
affect blood gases. Expired CO2 was monitored continuously from a small port in the tracheal tube 
(PowerLab gas analyzer, ML206, AD Instruments, Colorado Springs, CO) and remained constant 
during the experimental protocols. However, obtaining a true reading of end-tidal CO2 (i.e, one that 
equals PaCO2) is a challenge in small rodents. Therefore, we measured and report baseline blood 
gases in the three groups (naïve control, viral control and TeLC expressing rats; described in more 
detail below) of experimental animals in the first series of studies that involved viral injections and 
survival surgeries. Also in the initial hypoxia experiments involving the naïve and viral control 
groups, we measured blood gases before and during the hypoxic challenge to: i) ensure that we had 
control over blood gases; ii) determine the PaO2 achieved through pump ventilation with 10% O2, 
and; iii) ensure that blood gas and pH values were within physiological ranges and consistent between 
naïve rats and animals who had undergone survival surgery for viral injection. Since blood gases were 
consistent between groups (see Results), as expected for paralyzed animals on mechanical ventilation, 
blood gases were not taken during hypoxia in the remaining in vivo hypoxia studies (i.e., for the 
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TeLC animals during hypoxia and in subsequent acute experiments involving injection of MRS 
2279). 
Once the rat was placed in prone position in a stereotaxic device (Kopf Instruments, Tujunga, 
CA), and mechanically ventilated, the brachial plexus was exposed dorsolaterally behind the right 
shoulder blade. The phrenic nerve was isolated, cut distally, placed over dual platinum electrodes and 
embedded in kwik-sil adhesive (World Precision Instruments, Sarasota, FL) for long-term stability 
and to prevent nerve desiccation. 
Experiments that tested the acute effects of locally applying purinergic agonists into the 
preBötC were conducted in spontaneously breathing animals. The effects on blood gases of agonist-
evoked (DLH, MRS 2365, adenosine) ventilatory responses were not measured in spontaneously 
breathing animals due to the short duration of the agonist-evoked responses. Electrodes made from 
Teflon-coated wires (AM Systems, Carolsborg, WA) were placed in the genioglossus and diaphragm 
muscles to record electromyographic activity (GGEMG and DIAEMG, respectively). The animal was then 
positioned in a stereotaxic frame in prone position. Body temperature was maintained at 37°C in all in 
vivo experiments with a servo-controlled heating pad (Harvard Apparatus, Holliston, MA).  
 
Viral gene transfer in vivo 
Adult male rats (200-250 g) were anesthetized with a mixture of ketamine (90 mg/kg i.p.) and 
xylazine (10 mg/kg, i.p). They were then placed in a stereotaxic frame, where a small craniotomy was 
performed to expose the obex. Using coordinates described below, adenoviral vectors were injected 
bilaterally into the preBötC. Glial expression of tetanus toxin light chain (TeLC) and enhanced green 
fluorescent protein (eGFP) was achieved using a bicistronic adenoviral vector (AVV) construct as 
previously described, where eGFP expression was linked to TeLC via a “SKIP” sequence (Angelova 
et al., 2015). The bicistronic construct, making use of the viral ribosomal skipping mechanism, allows 
for a high expression of eGFP while attenuating TeLC expression to avoid cell toxicity. Vectors 
contained enhanced shortened GFAP promoter to drive expression of TeLC and eGFP (AVV-sGFAP-
eGFP-TeLC). As a control, we used an adenoviral vector (AVV) expressing eGFP only (AVV-
sGFAP-eGFP).  
 Viruses were diluted in HEPES buffer, and slowly injected into the preBötC under direct 
visualization (500 nl over 2 min). Following injection, the pipette remained in place for 5 min before 
withdrawal. The skin was sutured and the animal was put in post-operative care and closely observed 
throughout recovery from anesthesia. Rats were left to recover for 6-8 days before the in vivo 
experiments to ensure stable viral expression. Virus dilution and the post-injection incubation period 
were established through experiments that involved a series of 10-fold dilutions and incubation 
periods that varied from 5-9 days. Rats were euthanized at the end of the respective incubation period, 
perfused and tissue examined to define the dilution and incubation period that provided the strongest 
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glial expression with no evidence of tissue damage. High virus concentrations produced bright yet 
grainy fluorescent expression and transfected cell bodies near the injection site were hard to locate, 
consistent with cell death/damage. Low virus concentrations yielded weaker eGFP fluoresence, but 
individual cell bodies and processes were clearly identifiable. Original viruses of titres 1.4 x 10
11
 
(control) and 2.10 x 10
10
 (TeLC) were diluted 1:100.  
 
Recording of muscle and nerve activities in vivo 
In vivo recordings of EMG and phrenic nerve activities were amplified using a differential 
AC amplifier (model 1700, AM-systems, Sequim WA) and sampled at 2 kHz using a PowerLab 16/30 
data acquisition system (AD Instruments Colorado Springs, CO). Phrenic nerve activity was rectified, 
bandpass filtered (300 Hz to 1 kHz) and the raw signal was integrated (time constant = 0.08s) to 
calculate respiratory frequency and phrenic nerve inspiratory burst amplitude as an index of central 
respiratory drive.  
 
 
In vitro slice and glial culture methods 
 
Rhythmically-active medullary slice preparation 
Rhythmically-active medullary slices were obtained from neonatal rats (P0-P4) as described 
in detail previously (Smith et al., 1991; Ruangkittisakul et al., 2006; Zwicker et al., 2011). Briefly, 
rats were anesthetized through inhalation of isofluorane and decerebrated. The brainstem spinal cord 
was then isolated in cold artificial cerebrospinal fluid (aCSF) containing (in mM): 120 NaCl, 3 KCl, 
1.0 CaCl2, 2.0 MgSO4, 26 NaHCO3, 1.25 NaH2PO4, 20 D-glucose, and bubbled with 95% O2 – 5% 
CO2. The brainstem-spinal cord was pinned to a wax chuck, and serial 100-200 μm sections were cut 
in the rostral to caudal direction using a vibrating microtome (VT1000S, Leica, Nussloch, Germany). 
Sections were trans-illuminated to identify anatomical landmarks. The structure of the subnuclei of 
the inferior olive was particularly useful in defining this boundary. A 700 μm rhythmic transverse 
slice containing the preBötC was obtained. Special care was made to ensure that the preBötC was at 
the rostral surface of the slice (~0.35mm caudal to the caudal aspect of the facial nucleus) (Smith et 
al., 1991; Ruangkittisakul et al., 2006; Lorier et al., 2007; Ruangkittisakul et al., 2008). Rhythmic 
slices were pinned rostral surface up on Sylgard resin in a 5 ml recording chamber and perfused with 
aCSF at a flow rate of 15 ml/min (dead space of perfusion system including inflow and outflow lines 
and chamber was ~20 ml). The concentration of K
+
 in the aCSF ([K
+
]e) was raised from 3 to 9 mM at 
least 30 min before the start of data collection to produce prolonged stable rhythm (Ruangkittisakul et 
al., 2006). Rhythmic slice experiments were conducted at room temperature (24°C).  
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Primary cultures of glia isolated from the preBötC 
Culture preparation. Cultures were prepared from 300 μm thick preBötC slices from neonatal 
rats (P0-P4) as described in detail previously (Huxtable et al., 2010). Culture media were used at 
37 °C. The preBötC region was collected bilaterally using 21 gauge tissue punches. Tissue punches 
were transferred to separate 15 ml conical tubes, washed (2×) with Dulbecco‟s PBS (2 ml) 
(Invitrogen, Carlsbad, CA), and centrifuged (1500 × g, 1 min). PreBötC tissue was plated directly on 
Thermanox plastic coverslips (Invitrogen, Carlsbad, CA) and placed in a T25 flask containing BME-
glucose (1 ml) that was produced by adding to 1× basal medium Eagle solution (BME; Invitrogen, 
Carlsbad, CA): 3.3 mM glucose (final concentration of 8.8 mM), 2 mM L-Glutamine (Sigma-Aldrich, 
St. Louis, MO), penicillin/ streptomycin (10,000 U of penicillin/10,000 μg of streptomycin per ml; 
(Invitrogen, Carlsbad, CA), and 10% rat serum.  
PreBötC-containing coverslips were incubated in 1 ml of BME-glucose for the first 24 h and 
1 ml of BME-sorbitol (10% rat serum) thereafter. BME-sorbitol was equivalent to BME-glucose 
except that D-glucose was replaced with sorbitol (2.5 mM, Fisher Scientific, Waltham, MA) to select 
for glia. After 48 h, fresh media (with 2.5% rat serum) was added and changed every 3 days. Cultures 
were grown for 6 days, smeared, maintained in a 24-well plate for 2 weeks and then imaged.  
 
Recording of nerve and neuronal activities in vitro  
In vitro recordings of inspiratory activity were made using glass suction electrodes (AM 
Systems, Carlsborg, WA) placed on the XII (hypoglossal) nerve rootlets. Inspiratory-related field 
potentials were also recorded from the surface of the slice using a four-axis manual manipulator to 
place a suction electrode (120 m inside diameter) on the surface of the slice over the rostrally-
exposed preBötC (Ramirez et al., 1996). The pipette was systematically moved in 60 m steps until 
the most robust signal was detected. This technique was used to establish the approximate location of 
the preBötC to assist local drug injection. Signals were amplified, bandpass filtered (300 Hz to 1 
kHz), rectified, integrated and displayed using Axoscope 9.2 (Molecular Devices, Sunnyvale CA, 
USA). Data were saved using a Digidata 1322 A/D board and Axoscope 9.2 software for offline 
analysis. 
Responses of cultured glia were measured using Fluo-4 Ca
2+
 imaging. Cultures were loaded 
for 45 min (35°C) with the membrane-permeant Ca
2+
-sensitive dye, fluo-4-AM (0.01 mM, Sigma-
Aldrich, Oakville ON) in aCSF, containing the following (in mM): 117 NaCl, 5 KCl, 1 NaH2PO4, 2 
CaCl2, 1 MgSO4 , 26 NaHCO3 , and 6 glucose. Coverslips were then moved to the recording chamber 
(3 ml volume, 28°C, 6 ml/min flow rate) containing aCSF saturated with 20% O2, 5% CO2, 75% N2. 
Fluorescence intensity was measured using an upright microscope (Axioskop2 FS Plus, Zeiss, 
Oberkochen, Germany) fitted with a 40× water-immersion objective (NA = 0.8), xenon arc lamp (175 
W, Sutter Instruments, Novato, CA), and a Sensi-Cam QE (PCO Tech, Romulus, MI). Imaging 
  
 
This article is protected by copyright. All rights reserved. 
 
Workbench 6.0 (INDEC Bio- Systems, Santa Clara, CA) was used to control a Lambda 10-2 shutter 
system (Sutter Instruments, Novato, CA). Images were acquired at 1 Hz (20 ms exposure). Drugs 
(ATP 10 μM and thapsigargin 50 nM) were applied from triple-barreled micropipettes using a 
controlled pressure source. Consecutive agonist applications were 10 min apart. The locally-applied 
ATP concentration was 10-fold lower in these experiments compared to slice experiments because of 
improved drug access to glial monolayers. 
PreBötC inspiratory neuron activity was monitored in rhythmic slices using Fluo-4 Ca
2+
 
imaging or whole-cell recording.  In calibrated slices (Ruangkittisakul et al., 2006; Ruangkittisakul et 
al., 2008), the free cytosolic Ca
2+
 concentration ([Ca
2+
]i) was monitored by Olympus FV1000 MPE 
multiphoton scanning microscopy. A MaiTai-BB Ti:sapphire femtosecond pulsed laser set to excite at 
810 nm was used for fluorescence excitation and an Olympus X 20 1.0 NA immersion objective was 
used to image the neurons. The membrane-permeant Ca
2+
 dye fluo-4-AM was pressure-injected (25–
50 mmHg, 10 min) into the preBötC using a broken patch pipette filled with aCSF containing 0.5 mM 
Fluo-4-AM dissolved in dimethyl sulfoxide containing 20% pluronic acid (Sigma Aldrich, Oakville, 
ON). Neurons and glia, stained in an area of 150–300 µm diameter, were imaged in 30–75 µm depths 
for several hours at scanning rates of 2.5 Hz that are sufficient to resolve peaks of inspiratory-related 
[Ca
2+
]i rises (for details, see (Ruangkittisakul et al., 2006; Ruangkittisakul et al., 2012). 
Whole cell recordings were obtained from preBötC inspiratory neurons in rhythmic slices 
under direct infrared differential interference contrast microscopy (IRDIC) visualization. A horizontal 
puller (P-97, Sutter Instruments, Novato, CA) was used to pull patch pipettes from 1.2 mm o.d. 
filamented borosilicate glass (Harvard Apparatus, Holliston, MA). Pipette resistance was 5.1 ± 0.1 
MΩ. The intracellular solution used in this study contained (in mM): 140 potassium gluconate, 5 
NaCl, 1 MgCl2, 0.1 EGTA, 10 HEPES, and 1 glucose with pH adjust to 7.25-7.35. Intracellular 
signals were amplified and filtered (1.8 kHz low-pass Bessel filter) with a MultiClamp 700A 
amplifier (Molecular Devices, Sunnyvale, CA), acquired at 1 and 5 kHz using a Digidata 1322A A/D 
board (Molecular Devices, Sunnyvale, CA), for Axoscope 9.2 and Clampex 9.2 (Molecular Devices, 
Sunnyvale, CA), respectively, and stored to the computer‟s hard disk for off-line analysis using 
Clampfit 9.2.  
ATP was excluded from the intracellular solution because its inclusion would result in P2 
receptor desensitization as solution is pressure ejected from the pipette when approaching the neurons. 
Recordings were obtained under voltage-clamp conditions at a holding potential of -60 mV. 
Inspiratory neurons were identified based on the presence of rhythmic inward synaptic current inputs 
that were synchronized with inspiratory-related bursts recorded from the XII nerve rootlets. Neurons 
without rhythmic inputs were immediately discarded. Recorded neurons had an average resting 
potential of –48 ± 1.3 mV, input resistance values of 189 ± 40 MΩ and series resistance averaged 19.1 
± 1.5 MΩ. Short voltage pulses (100 Hz, -10 mV, 3.0 ms) were used to estimate series resistance and 
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whole-cell capacitance. The experiments where series resistance increased over 20% between control 
and trial conditions were excluded. Input resistance was calculated from the inverse of the slope of a 
linear regression line fitted to the I/V curves generated by depolarizing ramps from -90 to -40 mV. 
 
Immunohistochemistry 
 
At the end of the experiments, the rats were perfused transcardially with 10% saline (100 ml), 
followed by 4% paraformaldehyde (PFA, 100 ml). The brainstem was removed and submersion fixed 
for at least 24 hours in 4% PFA solution. The brainstems were sectioned serially into 50 μm slices in 
PBS solution using a vibratome (VT 1000S, Leica, Nussloch, Germany). The preBötC was identified 
based on anatomical landmarks; ~800 μm caudal to caudal border of the facial nucleus, at the same 
level as the lateral loop of the principal subnucleus of the inferior olive and the semi-compact nucleus 
ambiguus, just caudal to compact nucleus ambiguus (Paxinos & Watson, 2007; Ruangkittisakul et al., 
2008). The well-established preBötC marker, NK1 receptor immunolabeling, was also used to define 
the preBötC. Serial sections were examined for the region of most intense labeling indicative of the 
preBötC (Guyenet & Wang, 2001; Guyenet et al., 2002). MRS 2279 (P2Y1 receptor antagonist) 
injection sites were identified via fluorescent microspheres (1:200, 0.1 μm, yellow-green, 2% solids, 
Life Technologies). NK1 receptor immunolabeling was examined using a rabbit anti-NK1 receptor 
primary antibody (1:1000, cat#AB-5060, Millipore, Billerica, MA) with a Cy3-conjugated donkey 
anti-rabbit secondary (1:200, cat# 711-165-152, Jackson ImmunoResearch, West Grove, PA). To 
assess viral expression, eGFP fluorescence was enhanced with a chicken anti-GFP primary antibody 
(1:1000, cat# GFP-1020, Aves Labs, Tigard, OR) and an AlexaFluor 488 anti-chicken secondary 
antibody (cat# A-11039, Life Technologies, Carlsbad, CA). To check glial specificity of viral 
expression we used Cy3-conjugated NeuN rabbit antibody (1:200, cat# ABN78C3, Millipore) to stain 
neuronal nuclei. Slices were mounted on slides and observed with a fluorescent microscope 
(DM5500, Leica, Nussloch, Germany) and a Hamamatsu digital camera. Low magnification images 
to assess injection site were acquired through MetaMorph (Molecular Devices, Sunnyvale, CA) 
acquisition software, and the extent of viral expression analyzed using ImageJ (NIH, MD) and Adobe 
Photoshop (San Jose, CA). High magnification images were taken with a confocal microscope (Leica 
TCS SP5, Nussloch, Germany) to assess cellular expression patterns. Regions of interest were 
delineated by identifying NeuN labeled neuronal cell bodies under Cy3 fluorescence and then 
switching to GFP fluorescence to check for eGFP fluorescence indicative of neuronal expression of 
virally-transfected protein. 
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Drugs and their application 
 
In vivo. DL-Homocysteic acid (DLH)(1-10 mM) and Gallamine triethoiodide  were obtained 
from Sigma-Aldrich (St. Louis, MO), while MRS 2365 (1 mM), adenosine (500 μM) and MRS 2279 
(500 μM) were obtained from Tocris Biosciences (Bristol, UK). Pancuronium bromide was obtained 
from Alomone Labs (Jerusalem, Israel). Drugs were made up in HEPES-buffer (containing in mM; 
137 NaCl, 5.4 KCl, 0.25 Na2HPO4, 0.44 KH2PO4, 1.3 CaCl22H2O, 1.0 MgSO47H2O, 4.2 NaHCO3, 
10 HEPES) to maintain neutral pH. 
For preBötzinger drug injections, the head was tilted in the stereotaxic frame such that 
Bregma was 5 mm below Lambda (Gray et al., 2001). Drugs or vehicle (HEPES-buffer) were 
pressure injected (Picospritzer III, Parker, Pine Brook, NJ) into the preBötC through a reticuled, sharp 
glass pipette (40 μm tip). The preBötC was located using stereotaxic coordinates (in mm) that, relative 
to obex, were 0.9 rostral, 2.0 lateral and 2.8 ventral. Injection volume was monitored by observing the 
movement of the meniscus relative to the reticule. An excitatory response to DLH (1-10 mM) 
confirmed positive location of the preBötC (Monnier et al., 2003). With this approach, we were 
successful in targeting the preBötC on the first pipette tract in 83% of the experiments. In the 
remaining 17% of experiments, the pipette was moved rostrally or caudally and the expected response 
was evoked on the second injection. We did not notice any changes in network activity with second 
insertion of the electrode into the preBötC but this was not analyzed in detail. MRS 2279 solution 
contained fluorescent microspheres (0.1 μm, yellow-green, 2% solids, Life Technologies) for 
histological identification of injection sites in relation to NK1 receptor immunolabeling. 
 
 In vitro. Adenosine triphosphate (ATP, 10 μM), MRS 2365 (10 μM, 100 μM), MRS 2279 
(500 µM), DL-2-Amino-5-phosphono-pentanoic acid (AP5, 100 μM), thapsigargin (100 μM, 200 
μM), cyclopiazonic acid (CPA, 100 μM) and SP ([Sar9-Met(O2)
11
]-substance P (1 μM) were obtained 
from Tocris Biosciences. CNQX disodium salt (CNQX, 10 μM) and (+)-MK-801hydrogen maleate 
(MK-801, 100 μM) were obtained from Sigma-Aldrich (St. Louis, MO). Tetrodotoxin citrate (TTX, 
0.5 μM) was purchased from Alomone Labs (Jerusalem, Israel). Drugs were prepared as stock 
solutions in aCSF and frozen in aliquots except PPADS, suramin, TTX, CNQX, AP5 and MK-801 
which were prepared in MilliQ (EMD Millipore, Billerica, MA) water. Thapsigargin and CPA 
required DMSO (0.2%) for complete solubility. For drugs added in vitro, the final concentration of K
+
 
in the drug solution was matched to that of the aCSF.  
Drugs were injected unilaterally into the preBötC via triple-barrelled pipettes (5-6 μm per 
barrel outer diameter). Drug microinjections were controlled by a programmable stimulator (Master-
8; A.M.P.I., Jerusalem, Israel) connected to a picospritzer (~18 psi Spritzer4 Pressure Micro-Injector, 
Bioscience Tools, San Diego, CA). Consecutive agonist (MRS 2365) applications were separated by a 
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minimum of 15 min. The suction electrode on the surface of the slice was used to guide the initial 
placement of the pipette. Substance P (1 µM) was then locally applied to functionally identify the 
preBötC based on a characteristic immediate, 3-4 fold increase in inspiratory frequency (Lorier et al., 
2007; Zwicker et al., 2011). The injection site was moved in a grid-like fashion until the characteristic 
response was observed. When drugs (TTX, CNQX, AP5) were added directly to the circulating aCSF, 
they were given at least 10 min to equilibrate. During fluorescent imaging of inspiratory neurons, 
thapsigargin/CPA was given 30 minutes to equilibrate with the slice in a re-circulated bath (5ml/min, 
bath volume; 20 ml). 
 
Data Analysis 
 
Airflow, and electromyographic activity from the genioglossus and diaphragm muscles 
(GGEMG and DIAEMG) were acquired from spontaneously breathing rats. Airflow was measured via a 
pneumotach (GM instruments, Killwinning, Scotland UK) connected to a pressure transducer 
(Validyne, Northridge, CA) attached to the tracheal cannula and this signal was used to obtain 
frequency, tidal volume (VT) and minute ventilation (V E). VT was obtained by integration of airflow 
recording and converted to millilitres of air using a five-point calibration curve (0.5–5 ml range) 
(Boutin et al., 2017). Parameters during drug application were compared with the average value 
during a two-minute control period preceding drug application. Peak drug effect was defined as the 
maximum value measured in a moving average of three consecutive bursts during the first minute 
after the injection.  
Phrenic nerve activity, blood pressure and arterial blood gases were measured in paralyzed 
rats. Frequency, integrated phrenic nerve amplitude (∫PNA) and ventilatory output (frequency × 
∫PNA) were calculated from the phrenic nerve recording in LabChart (AD Instruments, Sydney, 
Australia), and exported to Microsoft Excel (Microsoft, Redmond, WA) for analysis. Respiratory 
parameters were calculated from 30-second time bins and reported relative to a two-minute control 
period preceding drug application. The HVR was characterized by comparing the peak values 
obtained during the initial hypoxia-induced increases in ventilation (phase I) and during the secondary 
depression when ventilation had plateaued (phase II). The peak value during phase I represents the 
group average of individual peak values obtained from a moving average measured during the first 
1.5 min of hypoxia. Phase II values represent the average measured over the last 2 min of hypoxic 
exposure (shaded areas in Figs. 3, 8 and 9). All signals from the in vivo experiments were acquired 
and integrated in LabChart (AD Instruments, Sydney, Australia). 
 XII nerve activity from rhythmic slices was analyzed offline using Clampfit 9.2 software 
(Molecular devices, Sunnyvale, CA) and Microsoft Excel (Microsoft, Redmond WA). To assess the 
effects of a specific agent on the frequency response evoked by local injection of P2 receptor agonists 
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into the preBötC, we compared the relative increase in peak frequency evoked by the agonist in 
control and in the presence of drug. Baseline frequency was the average frequency measured over the 
2 min immediately prior to drug application. Peak frequency was the peak value in the first min of 
drug application obtained from a moving average calculated based on three consecutive XII bursts 
(Huxtable et al., 2010; Zwicker et al., 2011). 
Differences between means were compared using either GraphPad Prism (Version 4, 
GraphPad Software Inc, La Jolla, CA) or SPSS (Version 20, IBM, North Castle, NY). For comparison 
of two groups, paired or unpaired t-tests were used as appropriate. For comparison of more than two 
groups, ANOVA was used in conjunction with either a Tukey or Bonferroni post hoc multiple 
comparison test. Unless specified otherwise, n refers to the number of rats. P values < 0.05 were 
considered significant. Group data are presented as boxplots created by the web-application 
„BoxPlotR‟ (Spitzer et al., 2014). Each boxplot details the spread of data points, which are 
superimposed on each box. Whiskers are defined by the lowest point, 1
st
 quartile, median, 3
rd
 quartile 
and highest point, denoted by the lower whisker, bottom, middle, top of box, and top whisker 
respectively. The mean for each group is denoted by “+”. 
 
RESULTS 
 
Astroglial vesicular mechanisms contribute to the hypoxic ventilatory response in vivo 
 
The overall reduction in the ventilatory response of conscious adult rats to hypoxia in 
conditions of TeLC expression in astrocytes of the ventrolateral medulla, including the preBötC 
(Angelova et al., 2015), indicates a significant contribution of medullary astroglia to the hypoxia-
induced increase in ventilation, by the release of gliotransmitters (Fig. 1 (ii)). The HVR, however, is 
biphasic. Thus, our first objective was to re-examine the contribution of glial vesicular release 
mechanisms by focusing on phases I and II of the HVR, 
Five to seven days after viral injection, the rats were anesthetized, paralyzed, vagotomized 
and mechanically ventilated. Phrenic nerve activity, BP and blood gases were monitored and the HVR 
compared between three groups of rats: naïve, control rats expressing eGFP in preBötC astrocytes, 
and rats expressing TeLC and eGFP in preBötC astrocytes. Baseline parameters were measured in 
normoxia (30% O2/70% N2) for two min. Baseline respiratory frequency, partial pressures of arterial 
PO2 and PCO2, and arterial pH were similar in control, viral control and TeLC expressing groups (Fig. 
2). Mean arterial pressures were also similar in naïve control rats (112.06 ± 4.92 mmHg) and TeLC-
expressing  rats (97.91 ± 12.69 mmHg), but elevated in the viral control group (137.15 ± 4.52 mmHg, 
One-way ANOVA, Tukey post-hoc test p = 0.008). Rats were then exposed to 5.5 min of hypoxia 
(10% O2, 90% N2) and returned to normoxia for two min. Sample traces from individual control and 
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TeLC rats as well as time courses calculated for group data are shown in Fig. 3A, B and reported 
relative to baseline. Comparisons of phase I and II parameters for the three groups are reported in Fig. 
3C. During phase I, the frequency and amplitude of the phrenic nerve discharge in naïve rats (n = 10) 
increased to a maximum of 1.41 ± 0.10 and 1.30 ± 0.04 of baseline respectively, giving a ventilatory 
output that was 1.79 ± 0.13 fold greater than the baseline. Rats transduced to express eGFP (n = 6) 
showed similar phase I increases in frequency, amplitude and the overall ventilatory output of 1.35 ± 
0.04, 1.44 ± 0.09 and 1.83 ± 0.09, respectively. The phase I response of rats expressing TeLC in 
medullary astrocytes was significantly reduced. Frequency and PNA amplitude were 1.16 ± 0.03 (n = 
6) and 1.25 ± 0.04 (n = 6) of control. Ventilatory output increased to 1.35 ± 0.06 (n = 6) of baseline, 
which was significantly smaller than in the naïve rats and rats transduced to express eGFP (p = 0.038, 
p = 0.041 One-way ANOVA, Tukey post-hoc test).  
During phase II of the HVR, the increases in frequency and PNA amplitude were not 
significantly different between the three groups. Frequency was 1.16 ± 0.07, 1.15 ± 0.04 and 0.97 ± 
0.04, and PNA amplitude was 1.28 ± 0.04, 1.29 ± 0.08 and 1.17 ± 0.04 for naïve, viral control and 
TeLC expressing rats, respectively. Ventilatory output, however, was significantly lower in the TeLC 
expressing rats (1.12 ± 0.04) compared to naïve (1.49 ± 0.09) and eGFP expressing rats (1.48 ± 0.09)  
(p = 0.024, p=0.048, respectively, One-way ANOVA; Tukey post-hoc test). Also, despite a modest 
elevation in the baseline mean arterial pressure of the viral control group compared to the naïve 
control and TeLC expressing rats, the drop in blood pressure during phase II relative to baseline was 
the same in all groups. These data indicate that the vesicular release of gliotransmitters by preBötC 
astrocytes contributes to the enhanced ventilatory activity in both phases of the HVR. 
Postmortem analysis of serial 50 µm transverse brainstem sections from rats expressing eGFP 
and TeLC in medullary astrocytes revealed the extent of viral expression across the ventral respiratory 
column (VRC) (Fig. 4A). Viral expression was similar in both groups. It was strongest at the level of 
the preBötC where the injection pipette tracts were visible. The injection sites were located ~750-850 
μm caudal to the caudal border of the facial nucleus at the same level as anatomical markers of the 
preBötC (lateral loop of the principal subnucleus of the inferior olive and the semi-compact division 
of nucleus ambiguus, just caudal to its compact formation (Paxinos & Watson, 2007; Ruangkittisakul 
et al., 2008). The strongest viral expression also overlapped with the site along the VRC with the 
highest density of NK1 receptor immunolabeling (Fig. 4B), an established marker of the preBötC 
(Gray et al., 1999; Guyenet & Wang, 2001; Guyenet et al., 2002). Viral expression dropped off 
substantially 500 µm rostral and caudal to the injection site centered in the preBötC (Fig. 4A).  
The morphology of all eGFP and TeLC-expressing cells was consistent with astrocytic 
targeting (Gourine et al., 2010; Angelova et al., 2015). The efficacy of our viral vectors in 
transfecting medullary astrocytes has been demonstrated previously (Liu et al., 2008; Gourine et al., 
2010; Tang et al., 2014). To further ensure the specificity and to determine whether TeLC is 
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expressed in preBötC neurons, we examined 253 transduced cells from 3 sections from 3 different 
animals for co-localization of eGFP expression with the immunoreactivity for a neuron specific 
marker NeuN. A representative example of eGFP and NeuN immunostaining and their overlay is 
shown in Fig. 4C. Ten NeuN labeled cells are circled to facilitate comparison. None of the NeuN 
labeled cells were transduced to express eGFP. 
 
P2Y1 receptor activation in the preBötC increases respiratory frequency in adult rats in vivo 
 
The previous experiments using using TeLC expression to block astroglial vesicular release 
did not identify the gliotransmitter(s) that excites the preBötC network. Substantial evidence, both in 
vivo (Gourine et al., 2005; Angelova et al., 2015) and in vitro (Lorier et al., 2004; Lorier et al., 2007) 
points to the involvement of ATP. The next objective was to assess whether P2Y1 receptors mediate 
the actions of ATP in the preBötC in vivo (Fig. 1, (iii)). We therefore tested whether local, unilateral 
injection of the P2Y1 receptor agonist, MRS 2365 (1 mM, n = 8) into the preBötC of anesthetized, 
vagotomized spontaneously-breathing adult rats increases respiratory frequency.  
The preBötC was functionally identified based on the stereotypical response to a 
microinjection of DLH (10 mM) that comprises a rapid-onset increase in inspiratory frequency and 
decrease in burst amplitude (Monnier et al., 2003), as shown in Fig. 5A. The excitatory effect of DLH 
was limited to a relatively small area. Injections 200 µm rostral to the preBötC (presumably in the 
BötC) reduced inspiratory frequency (Fig. 5B) while injections 300 µm caudal had no effect on 
breathing (Fig. 5C). 
A typical response of MRS2365 injection into the preBötC is illustrated in Fig. 6A. This 
recording, its corresponding time course (Fig. 6B) and group data (Fig. 6C) show that MRS 2365 
microinjections into the preBötC in vivo significantly increased respiratory frequency to 1.44 ± 0.09 
of control (p = 0.0013). VT decreased to 0.60 ± 0.09 of control (p = 0.0054). The amplitude of ∫DIA 
EMG and ∫GG EMG (not shown) inspiratory bursts decreased similarly to 0.60 ± 0.10 (p = 0.0049) 
and 0.60 ± 0.05 (p = 0.0002) of control, respectively (Fig. 6C). The increase in frequency and 
decrease in VT offset each other such that minute ventilation (VE) was not significantly affected by 
P2Y1 receptor activation, as expected in an actively breathing animal with intact chemoreceptor 
feedback mechanisms.  Parallel decreases in diaphragm and GG EMG suggest a decrease in central 
drive. However, we cannot exclude the possibility that the decrease in VT reflects an increase in 
airway resistance since GG EMG amplitude decreased. Nevertheless, the main result is that MRS 
2365 administration in the preBötC in vivo evokes an increase in respiratory frequency. Control 
(saline) injections into the same brainstem sites had no significant effect on the respiratory frequency, 
VT or VE.  
  
 
This article is protected by copyright. All rights reserved. 
 
Histological analysis of brainstem sections confirmed the functional DLH mapping. The 
fluorescent microspheres that marked the MRS 2365 injection sites were localized in a region 
corresponding to the preBötC based on anatomical criteria and the relationship to NK1 receptor 
immunolabeling as described above (Fig. 6D). Injection sites are mapped onto a schematic (Fig. 6D).  
 
Adenosine injection into the preBötC has no effect on ventilation in adult rats in vivo 
 
Degradation of extracellular ATP into adenosine can inhibit respiratory activity, but sites, 
mechanisms and the effects of adenosine appear to be species- and age-dependent. In rats, the 
adenosine mediated inhibition of the preBötC activity is completely blocked by the A1 receptor 
antagonist DPCPX and disappears by postnatal day 2-3. In mouse it is also A1 receptor mediated but 
lasts beyond postnatal day 3 (Huxtable et al., 2009; Zwicker et al., 2011). To determine whether the 
generation of adenosine from hydrolyzed ATP could have a confounding influence on responses 
evoked by ATP released by preBötC astrocytes in adult rats, we microinjected adenosine (500 nl, 500 
µM) unilaterally into the preBötC of adult, anesthetized, vagotomized rats. The representative traces 
and group data (Fig. 7A and C) show that injections of adenosine had no significant effect on 
ventilation. Frequency, VT and VE were 1.09 ± 0.03, 1.02 ± 0.01 and 1.09 ± 0.02 of control, 
respectively (n = 7, paired t-test p > 0.05). Responses elicited by DLH delivery into the same 
brainstem sites confirmed that the injections were placed within the preBötC (Fig. 7C). DLH caused a 
significant and rapid 1.36 ± 0.05 fold (p = 0.004) increase in frequency and parallel decrease in VT to 
0.67 ± 0.04 of control (p = 0.002) (Fig. 7C). Fluorescently-marked adenosine injection sites mapped 
to the preBötC based on anatomical landmarks (Fig. 7D). Fig. 7E shows a high magnification 
fluorescent image in which fluorescent microspheres that mark the injection site are in a region of 
strong NK1 receptor immunoreactivity.  
 
P2Y1 receptor blockade in the preBötC of adult rats increases the secondary hypoxic 
respiratory depression 
 
Given that ATP released in the ventral respiratory column during hypoxia appears to 
counteract the secondary respiratory depression (Gourine et al., 2005), and that ATP evokes P2Y1 
receptor mediated increases in respiratory activity by acting within the preBötC in vitro (Lorier et al., 
2007) and in vivo (Fig. 6), we tested the hypothesis that the secondary hypoxic depression is reduced 
by ATP-induced activation of P2Y1 receptors in the preBötC (Fig. 1 (iii)). We compared the HVRs of 
adult, urethane-anesthetized, paralyzed, mechanically ventilated and vagotomized rats following 
unilateral microinjections of vehicle (0.2 µl HEPES buffer) or the P2Y1 receptor antagonist, MRS 
2279 (0.2 µl, 500 µM) into the preBötC, two min prior to the onset of hypoxia. Integrated phrenic 
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nerve activity (∫PNA) was monitored as an index of central respiratory drive for two min in normoxia 
(30% O2 - 70% N2), five min in hypoxia (10% O2 - 90% N2) and then during the return to normoxia. 
Vehicle and MRS 2279 hypoxia trials were separated by one hour to ensure that the rats had fully 
recovered from the first hypoxic challenge. Representative recordings of ∫PNA in Fig. 8 show the 
hypoxic responses of one animal after vehicle and MRS 2279 microinjections into the preBötC.  
Blockade of P2Y1 receptors with MRS 2279 had no effect on baseline inspiratory frequency, 
phrenic burst amplitude or ventilatory output. Frequency was 45.7 ± 2.4 breaths/min at baseline and 
45.6 ± 2.5 after MRS 2279 injection; i.e., it remained at 99.8 ± 1.6% of baseline. Similarly, phrenic 
burst amplitude and ventilatory output remained at 99.4 ± 2.1% and 99.3 ± 3.6% of baseline after 
unilateral microinjections of MRS 2279 into the preBötC. 
Blockade of P2Y1 receptors with MRS 2279 also had no effect on the initial phase I of the 
HVR. In the control (after microinjections of the vehicle) hypoxia trials, frequency, burst amplitude 
and ventilatory output increased in phase I to levels that were 1.42 ± 0.08, 1.52 ± 0.11, and 1.83 ± 
0.23 fold greater than baseline, respectively. In MRS 2279, hypoxia evoked phase I increases in 
frequency, burst amplitude and ventilatory output that were 1.17±0.06, 1.23 ± 0.06 and 1.36±0.11 of 
baseline. Only the change in burst amplitude was significantly reduced compared to control during 
phase I (p = 0.038, paired t-test, n = 6).  
In contrast, MRS 2279 significantly reduced the respiratory activity during phase II of the 
HVR. In the vehicle trials, during phase II, frequency fell to 0.95 ± 0.07 of baseline and burst 
amplitude remained elevated at 1.34 ± 0.09 of baseline such that ventilatory output remained above 
the baseline level recorded during normoxia (1.28 ± 0.15). After MRS 2279 application, frequency 
and VE fell to the levels significantly below that seen in the vehicle controls and below baseline. 
Frequency fell to 0.62 ± 0.10 (p = 0.045, paired t-test, n = 6) of control while ventilatory output was 
0.73 ± 0.14 (p = 0.027, paired t-test, n = 6) of baseline. Group data are summarized in Fig. 8B 
Injection sites marked with fluorescent microspheres localized to the preBötC anatomically and based 
on the pattern of NK1 receptor immunolabeling (Fig. 8C).  
To ensure that the greater hypoxic depression following MRS 2279 microinjections into the 
preBötC was not due to time-dependent changes in the HVR with repeated hypoxic exposures, we 
performed a control series of experiments in which the hypoxia protocol was repeated at a one hour 
interval but the first and second hypoxic challenges were preceded by a vehicle injection. The 
frequency, ∫PNA amplitude and ventilatory output responses to the two consecutive hypoxic 
responses were not significantly different (Fig. 9, n = 5). Comparison of the second hypoxia response 
in this time control series with the hypoxia response in MRS 2279 from the previous series (i.e., 
unpaired data) also showed that during phase II MRS 2279 caused a significant reduction in both 
frequency and ventilatory output (p = 0.01 and 0.03 respectively, independent samples t-test).   
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Increases in [Ca
2+
]i contribute to the excitatory actions of P2Y1 receptor activation on the 
inspiratory rhythm generated by the preBötC  
 
Having shown that ATP acting at P2Y1 receptors in the preBötC contributes to the HVR in 
vivo, we next used rhythmic brainstem slice preparations to study the signaling pathways via which 
P2Y1 receptor activation excites the preBötC network (Funk et al., 1997; Lorier et al., 2004; Lorier et 
al., 2007; Lorier et al., 2008; Huxtable et al., 2009; Zwicker et al., 2011). Note that due to the 
limitations associated with using rhythmic medullary slices to explore mechanisms underlying 
homeostatic ventilatory responses to hypoxia (Funk and Greer, 2013), these studies do not examine 
responses to hypoxia/anoxia in vitro. Instead, our approach was to study mechanisms by which P2Y1 
receptor-mediated signaling pathways, which are activated in vivo during hypoxia, modulate preBötC 
network activity. Analyses of recombinant P2Y1 receptors and native P2Y1 receptors in other brain 
regions indicate that responses depend on increases in [Ca
2+
]i (Rajani et al., 2015). As depicted in Fig. 
1, [Ca
2+
]i dependent pathways can increase excitability by modulating the activity of multiple ion 
channels (Fig. 1 iv, v). We therefore tested the hypothesis that increases in [Ca
2+
]i are necessary for 
P2Y1 receptor activation to increase inspiratory frequency. We compared the responses of the preBötC 
network to local MRS 2365 administered after local application of vehicle or the Ca
2+
 chelator, 
EGTA-AM (1 mM). We used MRS 2365 rather than ATP because the frequency effect is mediated by 
P2Y1 receptors and because MRS 2365 avoids the confounding inhibitory actions on neonatal 
networks of adenosine that is generated from the degradation of ATP by endogenous 
ectonucleotidases. Vehicle and EGTA-AM (1 mM) were locally applied to the preBötC for 5 min (5 s 
on, 5 s off), prior to local application of MRS 2365 (10 s, 100 µM). EGTA-AM alone caused a 
significant, 30.6 ± 6.8% reduction in baseline inspiratory frequency from 12.2 ± 1.1 to 8.3 ± 0.7 
breaths/min. (n=6, p=0.007, paired t-test). As shown for a single slice preparation and group data in 
Fig. 10A, EGTA-AM also significantly reduced the MRS 2365-induced response from a 2.1 ± 0.14 
fold increase in control to a 1.5 ± 0.08 fold increase in EGTA-AM; i.e. EGTA reduced the magnitude 
of the MRS 2365 frequency increase by 59 ± 12% (n = 6, p = 0.0047, paired t-test). Reporting the 
MRS 2365-evoked frequency relative to baseline values may even underestimate the effects of 
EGTA. In control conditions, MRS 2365 caused frequency to increase from 12.2 ± 1.1 to 25.1 ± 1.8 
cycles/min, an increase of ~13 cycles/min. In contrast, in EGTA-AM MRS 2365 caused frequency  to 
increase from 8.3 ± 0.7 to 12.5 ± 1.2 cycles/min, and increase of ~4 cycles/min.  
To assess whether the increase in intracellular [Ca
2+
]
 
that contributes to the P2Y1 receptor 
evoked frequency increase is derived from intracellular sources, we next compared control MRS 2365 
responses evoked after vehicle (DMSO 0.2%) application with those evoked after local application of 
thapsigargin (200 μM) to the preBötC, a sarco/endoplasmic reticulum Ca2+ ATPase (SERCA) 
inhibitor that depletes intracellular calcium stores. Like EGTA-AM, the target of thapsigargin is 
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intracellular, but thapsigargin is not designed to facilitate diffusion across membranes. Thus, 
additional time was allowed for thapsigargin to diffuse into the tissue and cross cell membranes. MRS 
2365 applications were preceded by 30 minutes of pre-application (5s on, 5s off) of vehicle or 
thapsigargin. The response of a single preparation and group data are shown in Fig. 10C and 10D, 
respectively. First, application of thapsigargin for 30 minutes had no effect on baseline inspiratory-
related rhythm. Frequency was 13.4 ± 0.6 cycles/min in control and 14.2 ± 1.4 cycles/min 30 min 
after thapsigargin application. In contrast, 30 minutes of thapsigargin application reduced the MRS 
2365 evoked frequency increase from a 2.59 ± 0.15 fold increase to 1.90 ± 0.21 (n = 6, p = 0.007, 
paired t-test). A series of control experiments comparing the response of MRS 2365 before and after 
30 min local application of DMSO (0.2%) established that the thapsigargin-mediated inhibition was 
not due to the actions of the vehicle, but rather the effect of SERCA inhibition. Vehicle application for 
30 minutes did not affect the MRS 2365 response (n = 5, p>0.05, paired t-test). A different SERCA 
blocker, Cyclopiazonic acid (CPA, 100 µM), was tested using a similar protocol except that the 
vehicle contained 0.1% DMSO. Baseline inspiratory frequency was similar in control conditions (12.1 
± 2.5 cycles/min) and after 45 min CPA application (11.7 ±1.3 cycles/min). While CPA had no effect 
on baseline frequency, it reduced the MRS 2365-evoked frequency increase by ~35% from a peak of 
2.80 ± 0.28 fold in vehicle to 1.82 ± 0.12 after 45 min of CPA (n = 6, p = 0.040, paired t test; data not 
shown).  
 
P2Y1 receptor activation increases [Ca
2+
]i in preBötC inspiratory neurons and glia  
 
The EGTA and thapsigargin induced reductions in the P2Y1 receptor-evoked frequency 
increase indicates that increases in [Ca
2+
]i  are an important part of ATP mediated excitatory signaling 
in the preBötC. These data, however, do not establish whether the ATP-evoked frequency increase 
depends on an increase in neuronal [Ca
2+
]i, (Fig. 1 iv), glial [Ca
2+
]i, (Fig. 1 ii) or both. To gain insight 
into the cells that mediate the network excitation we tested whether inspiratory neurons and glia in the 
preBötC respond to ATP with an increase in [Ca
2+
]i. 
To test neuronal sensitivity we loaded the preBötC of rhythmic slices with the Ca
2+
-sensitive 
dye, Fluo-4. Fluo-4 fluorescence and XII inspiratory nerve activity were recorded during local 
application of MRS 2365 (100 µM) to the preBötC. Inspiratory neurons were identified by rhythmic 
increases in the Fluo-4 signal in phase with the rhythm recorded from the XII nerve (Fig. 11). Five 
such neurons are marked with arrows in Fig. 11A and their baseline, inspiratory-related oscillations in 
[Ca
2+
]i are apparent in the recordings of fluorescence intensity (Fig. 11B). Local application of MRS 
2365 (100 µM) near the surface of the slice evoked significant increases in preBötC frequency and the 
Fluo-4 signal in all 5 inspiratory neurons imaged in this slice (Fig. 11B). Group data taken from 18 
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inspiratory neurons in 5 slices showed a similar 1.53 ± 0.06 fold increase in the fluo-4 [Ca
2+
]i signal 
(Fig. 11C) (n = 18 from 5 slices, p < 0.0001, paired t-test).  
To test whether the MRS 2365-evoked increase in [Ca
2+
]i derives from intracellular sources, 
we compared the MRS 2365 response in control (1 min, 10 µM) with that evoked after the SERCA 
blocker thapsigargin (100 µM) or CPA (100 µM) was bath applied for 30 minutes. To account for any 
changes to the MRS 2365-evoked fluorescence due to photobleaching, two consecutive control MRS 
2365 applications were applied 30 minutes apart. The second control MRS 2365 response was then 
followed by the application of thapsigargin or CPA for 30 min and another MRS 2365 application. 
Two inspiratory neurons are marked in Fig 11D, along with their Fluo-4 fluorescence signals in Fig 
11E. We compared the decrease in fluorescence that occurred between MRS 2365 control trial 1 and 
control trial 2 with the decrease observed between control trial 2 and the trial with SERCA blockers. 
Thapsigargin (n = 8 neurons, 4 slices) and CPA (n = 4 neurons, 1 slice) had similar effects on the 
MRS 2365 evoked increase in Ca
2+ 
dye fluorescence, so these data were pooled (n = 12 neurons, 5 
slices). There was only a small decrease in Ca
2+
dye fluorescence between the two control trials; trial 2 
response was 95.0 ± 2.7 % of the first. In marked contrast, the reduction in the Ca
2+
 dye fluorescence 
response between the MRS 2365/thapsigargin trial and control trial 2 was significantly greater than 
the reduction in the MRS 2365 fluorescence response that occurred between control trials 1 and 2. In 
thapsigargin/CPA, the MRS 2365 evoked fluorescence increase was only 43.9 ± 7.3% of control trial 
2 (n = 12 neurons, 5 slices, p < 0.0001, paired t-test) (Fig. 11F).  
While the preBötC is the critical site for inspiratory rhythm generation, it contains multiple 
subtypes of inspiratory-related neurons that can be differentiated based on embryonic origin (Dbx1), 
peptide (SST) or peptide receptor (NK1, µ-opioid) expression, presence or absence of pacemaker 
properties and whether they are excitatory (glutamatergic) or inhibitory (GABAergic). The high 
sensitivity of the preBötC network to P2Y1 receptor excitation suggests that there may be a specific 
excitatory, ATP-sensitive population of preBötC neurons that either generates rhythm or provides 
drive to rhythm generating neurons. In contrast, if diverse excitatory and inhibitory preBötC 
inspiratory neurons are ubiquitously excited by ATP, one might predict blunted network sensitivity to 
ATP. As an initial foray into this important question, we simply asked whether all inspiratory 
modulated preBötC neurons are sensitive to P2Y1 receptor activation. As above, we used Ca
2+
-
imaging of Fluo4-loaded rhythmic slices, identified inspiratory neurons based on rhythmic Ca
2+ 
oscillations in phase with XII nerve output and counted cells that did or did not respond to MRS 2365 
with an increase in Ca
2+ 
fluorescence. In these experiments, MRS 2365 was bath-applied to activate as 
many neurons as possible and to prevent false negatives that can occur with local application when 
the drug does not diffuse from the pipette to the neuron in question. Neurons were only counted as 
weak- or nonresponders if there were other neurons in the same field of view that showed a strong 
response to MRS 2365. When all the data were grouped, 20 neurons from 7 slices showed an average 
  
 
This article is protected by copyright. All rights reserved. 
 
30.8+6.8% increase in fluorescence above baseline (data not shown). However, these 20 neurons 
could be divided into weak/non-responders and responders. Eight of the 20 neurons responded to 
MRS 2365 with an average increase in fluorescence of only 6.5+2.8%. The remaining 12 neurons 
were on average 7 times more sensitive, responding with an average 46.9+10.4% increase in 
fluorescence.  
To explore the signaling pathways through which ATP excites preBötC glial cells, glia were 
isolated from preBötC tissue punches and grown in culture using sorbitol in place of glucose as the 
metabolic substrate since only glia can utilize sorbitol. Cultures were loaded with Fluo-4-AM. Local 
application of ATP (10 µM, 10 s) evoked a 3.08 ± 0.2-fold increase in Ca
2+
dye
 
related fluorescence 
(Fig. 12), which we have shown previously is primarily mediated by P2Y1 receptors (i.e., it is blocked 
by MRS 2279 but neither suramin nor PPADS (Huxtable et al., 2010). Images of baseline 
fluorescence, the peak ATP response in control and after bath application of the SERCA blocker, 
thapsigargin (50 nM, 30 min), are shown for a group of cultured glial cells in Fig. 12A, along with the 
time course of fluorescence changes for four of these cells in Fig. 12B. Bath application of 
thapsigargin virtually blocked the ATP-evoked increase in Ca
2+ 
related fluorescence which rose to 
only 1.18 ± 0.03 of baseline (Fig. 12B, n = 54 cells from 4 culture plates, each plate was from one 
animal; p < 0.001, paired t-test).  
 
ATP-induced excitation of preBötC neurons does not involve glia-derived glutamate 
 
ATP (Angelova et al., 2015) and glutamate (Huxtable et al 2010) are major gliotransmitters 
that are released from cultured preBötC glia in response to hypoxia or ATP, respectively. Therefore, 
we next examined the possibility that during hypoxia, the autocrine/paracrine activation of astrocytes 
by ATP evokes additional gliotransmitter release, which could contribute to the HVR (Fig 1. vi). We 
tested this indirectly by determining whether stimulation of astrocytes with exogenous ATP evokes 
glutamate-mediated excitation of inspiratory neurons. In rhythmic slices, we obtained whole-cell 
voltage clamp recordings from preBötC inspiratory neurons, identified by rhythmic synaptic inputs in 
phase with inspiratory-related bursts in the XII nerve. We then applied TTX (0.5 µM) to block action 
potential dependent transmitter release and compared the neuronal response to locally applied ATP 
before and during application of glutamate receptor antagonists, CNQX (10 µM) and AP5 (100 
µM)/MK-801 (100 µM) (n = 8 cells from 8 slices). CNQX/AP5 was used in 3 of 8 experiments while 
CNQX/MK-801 was used in the other 5. Data were pooled since effects of AP5 and MK801 were the 
same. Because locally applied ATP can stimulate astrocytes and neurons, we predicted that if glial-
derived glutamate contributes to the neuronal ATP response, the ATP current would decrease in 
CNQX and AP5/MK-801. Due to the potential for time-dependent reduction in the amplitude of ATP 
currents, data obtained in the CNQX and AP5/MK-801 protocol were compared with a time-matched 
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control group that received repeated ATP injections at 15 min intervals. ATP currents are reported as 
a ratio of the difference between the ATP current amplitudes evoked in the first and second 
applications divided by the first current. A value of zero indicates that the first and second ATP 
currents were the same. A negative value indicates the second response was smaller than the first and 
vice versa. Fig. 13A shows a representative voltage clamp recording from an inspiratory neuron and 
currents evoked by ATP in control (pre-TTX, rhythmic inspiratory synaptic currents are present), after 
TTX and again after application of CNQX and AP5 (in the continued presence of TTX). The current 
traces and group data both indicate that there is no effect of glutamate receptor antagonism on the 
ATP current. The ATP current evoked in TTX plus CNQX+AP5/MK-801 groups was similar to that 
prior to addition of CNQX+AP5/MK-801; e.g., it was 0.2 ± 8.0% smaller than following the first ATP 
application. In the time-control group, ATP currents decreased 6.4 ± 4.7% between first and second 
applications. Similarly, CNQX+AP5/MK-801 had no effect on the reversal potential of the ATP-
evoked current or the associated reduction in neuronal input resistance. In control conditions (in TTX) 
the ATP current reversed at -26.5 ± 5.4 mV and was associated with a decrease in input resistance 
from 195 ± 40 MΩ to 148 ± 29 MΩ, (n=8) in ATP. In TTX/CNQX/AP5 (MK801), the ATP current 
reversed at 24.2 ±5.9 mV and caused input resistance to decrease from a baseline of 186 ± 35 MΩ 
to158 ± 35 MΩ in ATP (n=8). We did not examine ATP-evoked ATP release from astrocytes because 
P2 receptor antagonists would block the initial ATP response.  
 
DISCUSSION  
 
The biphasic ventilatory response of mammals to acute, moderate hypoxia comprises an 
initial, phase I increase in the first minute that is attributed to peripheral chemoreceptors, followed by 
a centrally-mediated secondary depression over several minutes to a new steady state phase II level. 
Our data complement emerging evidence of a central component to the excitation where glia act as 
hypoxia sensors and release ATP, exciting the respiratory network and offsetting the secondary 
respiratory depression (Angelova et al., 2015; Gourine & Funk, 2017). We advance mechanistic 
understanding by showing that the actions of ATP in the HVR are mediated in the preBötC through 
activation of P2Y1 receptors that increase inspiratory frequency in vitro via thapsigargin-sensitive 
increases in [Ca
2+
]i that occur in both inspiratory neurons and astroglia. Given the significant 
developmental changes that occur in both neuronal, and presumably glial (e.g., Zhou et al., 2006), 
components of the respiratory network, important future objectives will include assessing whether the 
mechanisms of P2Y1 receptor-mediated signaling defined here in neonates in vitro apply in adults 
during hypoxia and whether changes in glial signaling contribute to the greater hypoxic respiratory 
depression in prematurity. The fact that the P2Y1 receptor-mediated excitation of the preBötC 
network, defined first in rhythmic slices (Funk et al., 1997; Lorier et al., 2004; Lorier et al., 2007; 
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Lorier et al., 2008; Huxtable et al., 2009; Zwicker et al., 2011), is a major contributor to the excitatory 
actions of ATP released in vivo in hypoxia suggests that the combined in vitro – in vivo approach 
employed here will continue to be most insightful (Gourine & Funk, 2017). 
 
The role of glia and ATP in phase I and phase II of the hypoxic ventilatory response  
 
Evidence for gliotransmission in the intact CNS is sparse, reflecting the difficulty of 
selectively manipulating glial function. The contribution of gliotransmission to the HVR was first 
demonstrated by the reduction of the HVR in freely-moving rats following blockade of glial 
exocytosis through bilateral expression of TeLC in preBötC/VRC astrocytes (Angelova et al., 2015). 
Here, in paralyzed, mechanically ventilated rats, blockade of vesicular transmitter release in glia using 
TeLC suggests that gliotransmission contributes to both phases of the HVR.  
Unilateral microinjection of MRS 2279 into the preBötC, in contrast, did not affect the phase I 
increase, indicating that P2Y1 receptors in the preBötC do not contribute. Two protocol differences 
might account for this discrepancy. First, since TeLC blocks all vesicular release mechanisms but 
MRS 2279 selectively antagonizes P2Y1 receptors, the reduction of ventilation in phase I in 
conditions of TeLC expression in preBötC astrocytes may indicate a contribution of a non-P2Y1 
receptor-mediated component. Astrocytes release multiple transmitters, including glutamate and D-
serine, that could stimulate ventilation. ATP evokes glutamate release from cultured preBötC glia 
(Huxtable et al., 2010), but stimulation of glia in rhythmic slices with ATP does not cause 
glutamatergic excitation of inspiratory neurons (Fig. 13). 
Second, the region of the brainstem affected was different between TeLC and MRS 2279 
protocols. Viral injections were bilateral and centered in the preBötC, but expression extended up to 
>500 µm rostrally and caudally from the center of the injection site in preBötC. The MRS 2279 
injections were unilateral and, if MRS 2279 and DLH have similar diffusion profiles, likely extended 
less than 200 µm. Given that the bulk of evidence supports that the phase I response is mediated by 
carotid body chemoreceptors (Bureau et al., 1985; Fung et al., 1996; Prabhakar, 2000), the 
physiological significance of the inhibition of the phase I response mediated by expression of TeLC in 
astrocytes must be interpreted cautiously until the underlying mechanism is established.  
Our conclusion that gliotransmission contributes to the HVR depends on the selectivity of the 
bidirectional sGFAP-based vector system to interfere with exocytosis only in astrocytes. Glial 
specificity of this vector system (Liu et al., 2008; Gourine et al., 2010; Tang et al., 2014), and 
efficacy of TeLC in blocking exocytosis have been demonstrated (Angelova et al., 2015). Our 
analysis of transfected brain sections further suggests that TeLC expression is specific to astrocytes 
when under the control of the sGFAP promoter; no cells were detected that expressed eGFP and 
displayed NeuN immunoreactivity. 
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ATP acts via P2Y1 receptors to increase ventilation in vivo 
 
P2 receptors comprise seven ionotropic P2X (North, 2002) and eight metabotropic P2Y 
(Abbracchio et al., 2003) subtypes. P2Y1 receptor immunolabeling is prevalent throughout the VLM 
(Fong et al., 2002) and overlaps with intense NK1 receptor expression, an established marker of the 
preBötC. Indeed, P2Y1 receptors underlie the excitatory actions of ATP in the preBötC in vitro 
(Lorier et al., 2007). Here we translate these in vitro findings and reveal, using unilateral injections of 
MRS 2279, that endogenous activation of preBötC P2Y1 receptors in vivo increases ventilation and 
attenuates the secondary hypoxic respiratory depression. The fact that antagonists were only applied 
unilaterally means that our measurements may underestimate the magnitude of the P2Y1 receptor-
mediated increases in ventilation during hypoxia. Whether P2Y1 receptors are the only P2 receptor 
subtype involved in the HVR is uncertain, as a variety of P2 receptors are expressed in the VRC 
(Thomas et al., 2001; Fong et al., 2002; Gourine et al., 2003; Lorier et al., 2004; Lorier et al., 2007). 
Nonetheless, our data illustrate a significant role for P2Y1R in the ATP-induced increase in ventilation 
in the preBötC during hypoxia. 
 
Adenosine inhibition of the preBötC network does not contribute to the hypoxic respiratory 
depression in adult rat   
 
Experiments were not designed to identify the mechanisms underlying the hypoxic respiratory 
depression, but our data provide some insight. First, the P2Y1 receptor-mediated attenuation indicates 
that the secondary depression is not shaped by a single inhibitory mechanism. Second, adenosine 
inhibition of the preBötC network does not contribute to the depression in adult rats. The enhanced 
hypoxic respiratory depression observed in adults rats expressing the ectonucleotidase TMPAP in the 
preBötC and VRC (Angelova et al., 2015) is due to degradation of excitatory ATP rather than 
accumulation of adenosine. Also, hypoxia-induced adenosine release has been detected in the NTS of 
adult rats, but not in the VLM (Gourine et al., 2002). 
Developmentally, adenosine plays a more important role. An A1 receptor inhibitory 
mechanism is implicated in the secondary hypoxic depression in a host of premature/newborn 
mammals including pigs, sheep, (Moss, 2000), rats and mice (Funk et al., 2008; Huxtable et al., 2009; 
Zwicker et al., 2011). Developmental analyses are required in multiple species to assess whether A1 
inhibitory mechanisms disappear postnatally, as occurs in P2-3 rats (Herlenius et al., 1997; Huxtable 
et al., 2009). Medullary and suprapontine A2a receptor-mediated excitation of GABAergic inhibitory 
neurons may also contribute to the depression in piglets and fetal sheep, (Koos & Maeda, 2001; Koos 
et al., 2001; Wilson et al., 2004), but these actions do not appear to be through A2a receptor 
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mechanisms in the preBötC, since inhibition of rhythm by adenosine within the preBötC (in rats and 
mice) is completely blocked by the A1 receptor antagonist DPCPX (Huxtable et al., 2009; Zwicker et 
al., 2011). 
 
Signaling pathways of the P2Y1 receptor-mediated excitation; neurons versus glia 
 
The only identified source of extracellular ATP during hypoxia is from astrocytes (Angelova 
et al., 2015). Thus, our working hypothesis is that, during hypoxia, astrocyte-derived ATP increases 
inspiratory frequency primarily through excitation of preBötC inspiratory neurons but also through 
autocrine/paracrine excitation of astrocytes causing further gliotransmitter release (Fig. 1 iii, vi). 
Consistent with this hypothesis, both preBötC inspiratory neurons (in slices, Fig. 11) and preBötC glia 
(in slices and culture (Fig. 12) (Huxtable et al., 2010) respond to ATP via a P2Y1 receptor signaling 
pathway that involves a thapsigargin-sensitive increase in [Ca
2+
]i and a neuronal inward current 
(Lorier et al., 2008). The ion channels underlying this inward current have yet to be identified, though 
candidates have been proposed (Rajani et al., 2015). 
ATP-induced excitation of neurons is clearly involved in preBötC excitation. However, a role 
for autocrine/paracrine excitation of astrocytes by ATP remains to be established. Autocrine/paracrine 
excitation was first implicated with the observations that glial toxins attenuate the frequency increase 
evoked by ATP in the preBötC in vitro and that cultured preBötC astrocytes release glutamate in 
response to ATP (Huxtable et al., 2010). In contrast, imaging of cultured brainstem astrocytes 
suggests that ATP does not signal via paracrine/autocrine mechanisms; low pH and hypoxia-evoked 
fusion of putative ATP-containing vesicles was unaffected by ATP degrading enzymes or P2Y1 
receptor antagonists (Kasymov et al., 2013; Angelova et al., 2015). The sparse nature of these 
astrocyte cultures could have compromised detection of autocrine/paracrine signaling. However, our 
whole-cell data showing that ATP does not evoke glutamatergic excitation of inspiratory neurons 
suggest that preBötC astrocytes in situ do not respond to ATP by releasing a transmitter, and that 
autocrine/paracrine ATP signaling may not contribute to the HVR. 
 
[Ca
2+
]i  increases contribute to P2Y1 receptor-mediated inspiratory frequency increase 
 
Analysis of recombinant receptors suggests that P2Y1 receptors predominantly signal through 
the Gαq/11 pathway, which involves activation of PLC, release of Ca
2+
 from intracellular stores, and 
DAG-mediated activation of protein kinase C (Simon et al., 1995; von Kugelgen & Wetter, 2000; Sak 
& Illes, 2005). Here we show that an increase in [Ca
2+
]i contributes to the P2Y1-mediated frequency 
increase in vitro, which implicates a Ca
2+
-dependent, second messenger pathway that is dependent on 
[Ca
2+
]i. The ATP/MRS 2365-mediated frequency increase, however, was not completely blocked by 
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EGTA-AM or thapsigargin (Fig. 10). Thus, either the block of [Ca
2+
]i changes was incomplete or 
Ca
2+
-insensitive pathways may contribute. P2Y1 receptors can also signal through Gαi and alter ion 
channel activity through the membrane-delimited βγ subunit without changing [Ca2+]i (Brown et al., 
2000; Filippov et al., 2000; Aoki et al., 2004). To fully elucidate these mechanisms, a deeper 
exploration of signaling pathways and downstream candidate ion channels underlying the P2Y1-
evoked excitation of the preBötC is required (Rajani et al., 2015). 
 
Significance 
 
Understanding the multitude of factors that determine the dynamics of the HVR is key in the 
development of strategies to counteract the hypoxia-induced depression of breathing. We have 
identified an endogenous P2Y1 receptor mechanism that attenuates this depression in adults and is 
active in embryonic stages through to adulthood in mammals. Degradation of ATP in the preBötC 
will contribute to the depression by removing excitatory actions of ATP, but also by producing 
adenosine, which is inhibitory in the perinatal period and has variable effects into adulthood. 
Strategies to minimize the hypoxic depression of ventilation should aim to enhance P2Y1 receptor-
mediated signaling, inhibit ATP degradation and enhance removal of adenosine from the extracellular 
space of the brainstem. 
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FIGURE CAPTIONS 
Figure 1: Purinergic modulation of respiratory rhythm: a working hypothesis. 
At the synapse of two preBötC inspiratory neurons, volleys of action potentials during inspiration in 
the presynaptic neuron evoke glutamate release, exciting postsynaptic neurons via ionotropic (GluR) 
and metabotropic (mGluR) receptors on preBötC inspiratory neurons. During hypoxia, astrocytes 
sense changes in O2, causing increases in intracellular calcium (i), resulting in the exocytotic release 
of gliotransmitters, including ATP (ii). ATP acts via P2Y1 receptors located on preBötC neurons (iii), 
causing a release of Ca
2+
 from intracellular stores mediated by DAG/IP3 (iv), and the modulation of 
downstream ion channels, [Ca
2+
]i, or the activation of protein kinase C (PKC) (v). Autocrine/paracrine 
of astrocytes by ATP may also contribute (vi).  
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Figure 2: Baseline parameters in the naïve control rats and rats transduced to express eGFP or 
TeLC in the preBötC astrocytes. 
Group data indicating the absolute values of respiratory frequency (A), mean arterial pressure (B), 
arterial PO2 and PCO2 (C), and pH (D) under baseline conditions, prior to the administration of 
hypoxia for the naïve control, viral control as well as the TeLC expressing rats. (* indicates 
significant difference between means, p < 0.05, One-way ANOVA, Tukey post-hoc test). 
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Figure 3: Expression of tetanus toxin light chain (TeLC) protein in medullary astrocytes 
attenuates the hypoxic ventilatory response. 
A) Representative recordings obtained in naïve control and TeLC expressing rats showing changes in 
integrated phrenic nerve activity (∫PN), instantaneous frequency (inst. freq., breaths per min, BPM) 
and blood pressure during 5.5 min of exposure to 10% O2. B) Time courses of relative frequency, 
integrated phrenic nerve amplitude (∫PNA) and ventilatory output (frequency × ∫PNA) calculated for 
the three groups: naïve controls (n = 10), viral controls (n = 6) expressing eGFP in astroglia, and rats 
expressing eGFP and TeLC in astroglia (n = 6). Phases I and II of the HVR are shaded in grey. C) 
Box plots comparing phase I and II parameters across the three groups (* indicates significant 
difference between means, p < 0.05, One-way ANOVA, Tukey post-hoc test).  
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Figure 4: Viral expression was centered at the level of the preBötC and limited to 
astrocytes. A) Schematic showing relative location of peak viral expression with respect to 
the preBötC in adult rats targeted with AVV-sGFAP-eGFP-TeLC. Inferior olive dorsal (IOD), 
inferior olive medial (IOM), inferior olive principal (IOP), 4th ventricle (IV), nucleus ambiguus 
(NA), pyramidal tract (PY), rostral ventrolateral medulla (RVL), spinal trigeminal tract (Sp5), 
spinal trigeminal interpolar (Sp5I), solitary tract (Sol). Viral expression was centered in the 
preBötC and dropped off substantially 500 µM rostral and caudal to the injection site that 
was centered in the preBötC. B) The region expressing TeLC-eGFP adenovirus is centered in 
the region containing a high density of NK1 receptor expressing neurons, are present in. C) 
Double-labeling of cells with the neuronal marker NeuN and the glial specific adenovirus, 
detected via eGFP, was not detected. Ten NeuN labeled cells are circled to facilitate 
comparison between images). 
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Figure 5: Functional identification of preBötC via microinjections of DLH. Unilateral injection of 
DLH (10 mM) into the VLM of urethane-anesthetized, paralyzed adult rats while measuring 
instantaneous respiratory frequency (inst. freq.) from phrenic nerve activity (∫PN). A) Unilateral 
injection of DLH into the preBötC produces a robust increase in respiratory frequency. B) Injection of 
DLH 200 µm rostral to the preBötC (presumably in the BötC) reduced inspiratory frequency. C) DLH 
injection 300 µm caudal to the preBötC had minimal effect on inspiratory rhythm. 
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Figure 6: Activation of P2Y1 receptors in the preBötC of adult rat in vivo with MRS 2365 (1 
mM) evokes an increase in respiratory frequency and a decrease in tidal volume (VT) A) Airflow 
and diaphragm (DIA) EMG recordings show the response of an adult anesthetized vagotomized rat to 
unilateral injection of MRS 2365 (1mM, 200nl) into the preBötC. B) Time course of instantaneous 
frequency (inst. freq.), VT, and minute ventilation (V E) responses evoked by a single injection of MRS 
2365.  C) Group data (n = 8) illustrating the change in frequency, VT and V E relative to control (* 
indicates significant different from predrug control values, p < 0.05, paired t-test). D) Schematic 
showing 8 injection sites. Inferior olive dorsal (IOD), inferior olive medial (IOM), inferior olive 
principal (IOP), 4
th
 ventricle (IV), nucleus ambiguous (NA), pyramidal tract (PY), rostral ventrolateral 
medulla (RVL), spinal trigeminal tract (Sp5), spinal trigeminal interpolar (Sp5I), solitary tract (Sol). 
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Figure 7: Adenosine (500 μM) microinjected into the preBötC of adult rat in vivo has no effect 
on respiratory frequency or tidal volume (VT). A) Airflow, diaphragm (DIA) and genioglossus 
(GG) EMG recordings show the response of an adult anesthetized vagotomized rat to unilateral 
injection of adenosine into the preBötC. B) Airflow, diaphragm (DIA) and genioglossus (GG) EMG 
recordings show the response of an adult anesthetized vagotomized rat to injection of DLH (1 mM) 
into the preBötC. C) Group data illustrating the change in frequency and VT relative to control (n = 8) 
(* indicates significant difference from predrug controls values, p <  0.05, paired t-test). D) Schematic 
showing 8 injection sites in relation to inferior olive dorsal (IOD), inferior olive medial (IOM), 
inferior olive principal (IOP), 4
th
 ventricle (IV), nucleus ambiguus (NA), pyramidal tract (PY), rostral 
ventrolateral medulla (RVL), spinal trigeminal tract (Sp5), spinal trigeminal interpolar (Sp5I), solitary 
tract (Sol). E) Tissue section showing injection site marked with fluorescent microspheres (yellow). 
PreBötC neurons (NK1
+
) are present in the region of the injection site. 
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Figure 8: Unilateral inhibition of P2Y1 receptors in the preBötC of adult paralyzed rats in vivo 
with MRS 2279 increases the secondary hypoxic respiratory depression. A) Representative traces 
showing changes in integrated phrenic nerve activity (∫PN) and instantaneous frequency (inst. freq. 
BPM) evoked by exposure to 5 min of 10% O2 following injection of vehicle (HEPES) or MRS 2279 
into the preBötC. B) (Left) Time courses of relative frequency, integrated phrenic nerve amplitude 
(∫PNA) and ventilatory output (frequency × ∫PNA) calculated before and after injection of MRS 2279 
(n = 6). Phases I and II of the HVR are shaded in grey. (Right) Comparisons of phase I and II 
parameters between vehicle and MRS 2279 responses (* indicates significant difference between 
control (HEPES) and MRS 2279 trials, p < 0.5, paired t-test). C) Schematic showing 6 injection sites. 
Inferior olive dorsal (IOD), inferior olive medial (IOM), inferior olive principal (IOP), 4
th
 ventricle 
(IV), nucleus ambiguus (NA), pyramidal tract (PY), rostral ventrolateral medulla (RVL), spinal 
trigeminal tract (Sp5), spinal trigeminal interpolar (Sp5I), solitary tract (Sol).  
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Figure 9:  The hypoxic ventilatory response does not change with repeated exposure; time-
matched controls. A) Representative traces from the same animal showing changes in integrated 
phrenic nerve activity (∫PN) and instantaneous frequency (inst. freq., BPM) during two consecutive 
hypoxic exposures (1 hour apart) following stereotaxic injection of vehicle (HEPES) into the 
preBötC. B) (Left) Time courses of relative frequency, integrated phrenic nerve amplitude (∫PNA) and 
ventilatory output (frequency × ∫PNA) calculated before and after injection of MRS 2279 (n = 6). 
Phases I and II of the HVR are shaded in grey. (Right) Box plots comparing these same parameters 
during phases I and II of the HVR during consecutive exposures to hypoxia under control conditions 
(i.e., after HEPES injection). 
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Figure 10: Increases in [Ca
2+
]i contribute to the P2Y1 receptor mediated frequency increase in 
vitro. A) Representative traces of integrated hypoglossal nerve output (∫XII) evoked in response to 
P2Y1 agonist MRS 2365 (10s, 100 μM) before and after the local application of the cell permeable 
calcium chelator EGTA-AM (1 mM) to the preBötC. B) Box plot summarizing group data (* 
indicates significant difference between means, n = 6; p = 0.0047, paired t-test). C) Representative 
traces ∫XII nerve output evoked in response to MRS 2365 (10 s, 100 μM) in control and after local 
application of thapsigargin (30 min, 200 μM). D) Box plot of group data showing effects of 
thapsigargin on the MRS 2365 evoked frequency increase (2 left-most boxes, n = 6) and time matched 
control experiments showing effects of repeated vehicle injections (0.2% DMSO, n = 5) on the MRS 
2365 response (* indicates significant difference between means, p < 0.05, paired t-test).  
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Figure 11: Activation of P2Y1 receptors on preBötC inspiratory neurons in vitro evokes a 
thapsigargin-sensitive, increase in [Ca
2+
]i. A) Multiphoton images of baseline Fluo-4
 
fluorescence 
indicating [Ca
2+
]i in 5 inspiratory neurons at a single optical plain (top), inspiratory-related 
oscillations in [Ca
2+
]i and the peak [Ca
2+
]i increase evoked in response to locally applied MRS 2365 
(100 µM, 10 s) (bottom) B) [Ca
2+
]i increases in the neurons of (A) are synchronous with ∫XII and their 
responses to locally applied MRS 2365 (100 µM, 10 s). C) Group data showing an approximate 50% 
increase in peak Fluo-4 fluorescence in response to local application of MRS 2365 (100 µM, 10 s) 
over inspiratory preBötC neurons (n = 18, 5 slices; * indicates significant difference between means, p 
< 0.0001, paired t-test); A.U., arbitrary units. D) Multiphoton images of Fluo-4  Ca
2+
 fluorescence in 2 
inspiratory neurons at a single optical plain at baseline (top), at the peak of two control MRS 2365-
evoked (10 µM, 1 min, bath application) Ca
2+ 
fourescence responses  (top middle, bottom middle), 
seperated by 30 minute intervals. The bottom image shows the response evoked by MRS 2365 after 
bath application of thapsigargin (100 µM, 30 min). E) Traces of Fluo-4 Ca
2+
 flourescent responses 
evoked by MRS2365 in the same neurons shown in (D). F) Box plot of group data comparing the 
decrease in peak MRS 2365-evoked Fluo-4  Ca
2+
 response that occurred between control response 1 
and 2 with the decrease in the MRS 2365-evoked Ca
2+
 response that occurred between the second 
control MRS 2365 response and the MRS 2365 response in thapsigargin (or CPA)(n = 12, 5 slices; * 
indicates significant difference between means, p < 0.0001, paired t-test). 
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Figure 12: Responses of cultured preBötC glia to ATP are sensitive to depletion of 
intracellular calcium stores. A) Images showing a phase contrast image of cultured glia (far 
left panel), and fluo-4 Ca2+ fourescence under baseline conditions (middle-left panel), during 
local application of ATP (10 μM, 10 s,) (middle-right panel), and during local application of 
ATP after pre-application of SERCA inhibitor thapsigargin (50 nM, 30 min) (far right panel). 
B) Time course of ATP-evoked fluorescence changes measured from 4 ROIs (numbered in A) 
in control (left), and after thapsigargin application (middle). Group data (n = 54 cells, from 4 
culture plates, each plate was from one animal) showing relative changes in fluorescence 
(Fpeak/Fbaseline) in response to ATP and to ATP in the presence of thapsigargin (right) (n = 54 
cells; * indicates significant difference between means p < 0.001, paired t-test).  
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Figure 13: Effect of CNQX and AP5/MK-801 on ATP currents evoked in preBötC 
inspiratory neurons in TTX.  
A) Representative traces showing an ATP current evoked in an inspiratory preBötC neuron in a 
rhythmic slice (note inspiratory synaptic currents pre-TTX), after TTX and again in TTX after bath 
application of CNQX (10 µM) and AP5 (100 µM). B) Group data comparing the relative reduction in 
the ATP current that occurs with consecutive applications in a time matched-control group (n = 6 cells 
from 6 slices) with reduction that was produced by CNQX+AP5/MK-801 group (n = 8 from 8 slices).  
 
 
